Roxana Mehran, MD, Appointed 74th President of American College of Cardiology at 2026 New Orleans Congress

Mount Sinai’s Dr. Roxana Mehran becomes the 74th ACC President. She will lead global efforts in cardiovascular innovation, health equity, and digital transformation.

By: AXL Media

Published: Mar 30, 2026, 6:27 AM EDT

Source: Information for this report was sourced from The Mount Sinai Hospital / Mount Sinai School of Medicine

A Historic Leadership Transition in New Orleans

The American College of Cardiology has officially inaugurated Roxana Mehran, MD, as its newest President during a convocation ceremony held on Monday, March 30, in New Orleans. Dr. Mehran’s appointment marks a significant milestone for the Mount Sinai Health System, as she is the first woman from the hospital to lead the prestigious professional body. The last time a Mount Sinai clinician held this title was exactly one century ago, when Dr. Simon Dack served as president in 1926. As the 74th leader of the organization, Dr. Mehran assumes the role of chief spokesperson and Chair of the Board of Trustees, tasked with steering the strategic vision of nearly 60,000 cardiovascular professionals worldwide.

Advancing Global Equity and Clinical Innovation

Upon her appointment, Dr. Mehran articulated a mission centered on the integration of innovation and equity within the field of cardiovascular medicine. Her tenure is expected to prioritize global collaboration, specifically strengthening ties with the American Heart Association and the European Society of Cardiology to address heart health disparities. According to Dr. Mehran, the goal of her presidency is to drive a digital transformation that makes cutting-edge research more accessible while mentoring the next generation of cardiac leaders. This vision aligns with her career-long dedication to outcomes research and the implementation of large-scale randomized clinical trials.

Academic and Research Foundations at Mount Sinai

Dr. Mehran currently serves in multiple high-level capacities at the Icahn School of Medicine at Mount Sinai, including Director of the Women’s Heart and Vascular Center at the Fuster Heart Hospital. Her extensive research portfolio includes over 2,000 peer-reviewed articles and the development of personalized risk scores for acute kidney injury and bleeding. Dr. Valentin Fuster, Physician-in-Chief of The Mount Sinai Hospital and a past president of the American Heart Association, praised her leadership as exemplary, noting that her fortitude and vision are essential for the College’s success during a period of rapid technological change in medicine.